Shijiazhuang Yiling Pharmaceutical Co., Ltd. Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

002603

Pozycja w akcjach #4266
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Cena akcji
$2.22
Kapitalizacja rynkowa
$3.71B
Zmiana (1 dzień)
-0.13%
Zmiana (1 rok)
-7.34%
Kraj
CN
Handel Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)

Kategoria

Healthcare
Historia dywidend dla Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (symbol giełdowy: 002603) wypłaciła łącznie 14 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): $2.68
Wskaźnik dywidendy (TTM): 0.0532
Wypłaty dywidend dla Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603) od 2012 do 2026
Roczne wypłaty dywidend
Rok Dywidenda (skorygowana o podziały akcji) Zmień
2026 (TTM) $0.3 0.00%
2025 $0.3 0.00%
2024 $0.3 -40.00%
2023 $0.5 66.67%
2022 $0.3 -58.00%
2021 $0.7143 399.86%
2020 $0.1429 100.14%
2019 $0.0714 0.00%
2018 $0.0714 0.00%
2017 $0.0714 0.00%
2016 $0.0714 100.00%
2015 $0.0357 0.00%
2014 $0.0357 0.00%
2013 $0.0357 29.82%
2012 $0.0275 0.00%
Lista wszystkich wypłat dywidend
Rok Dywidenda Zmień
2026 (TTM) $0.3 0.00%
2025 $0.3 0.00%
2024 $0.3 -40.00%
2023 $0.5 66.67%
2022 $0.3 -70.00%
2021 $1.00 400.00%
2020 $0.2 100.00%
2019 $0.1 0.00%
2018 $0.1 0.00%
2017 $0.1 0.00%
2016 $0.1 0.00%
2015 $0.1 0.00%
2014 $0.1 0.00%
2013 $0.1 0.00%
2012 $0.1 0.00%
Wypłaty dywidend firm podobnych lub konkurencyjnych